WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Crispr Therapeutics Ag earnings were -$385.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CRSP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$136.0M, up 264.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRSP reported annual earnings of -$366.3M, with 138.4% growth.

CRSP earnings history

Current Revenue
$37.7M
Current Earnings
-$385.7M
Current Profit Margin
-1,023.6%

CRSP Return on Equity

Current Company
-20.1%
Current Industry
-60.2%
Current Market
31.5%
CRSP's Return on Equity (-20.1%)... subscribe to Premium to read more.
High Return on Equity Performance

CRSP undefined

Current Company
-17.1%
Current Industry
-2.5%
CRSP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CRSP announces earnings.

CRSP undefined

Current Company
-18.65%
Current Industry
5.8%
CRSP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRSP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CRSP-$362.52M-$385.66MN/A-$4.50
SRPT-$109.09M-$248.39MN/A-$2.51
RARE-$511.44M-$549.58MN/A-$5.87
SWTX-$247.19M-$253.93MN/A-$3.41
ACAD$278.16M$228.88MN/A$1.38
View Top Biotech Stocks

Crispr Therapeutics Ag Earnings Reports & History FAQ

What were Crispr Therapeutics Ag's earnings last quarter?

On CRSP's earnings call on Invalid Date, Crispr Therapeutics Ag (NASDAQ: CRSP) reported Q1 2025 earnings per share (EPS) of -$1.58, up 10.49% year over year. Total CRSP earnings for the quarter were -$136.00 million. In the same quarter last year, Crispr Therapeutics Ag's earnings per share (EPS) was -$1.43.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.

Is Crispr Therapeutics Ag profitable or losing money?

As of the last Crispr Therapeutics Ag earnings report, Crispr Therapeutics Ag is currently losing money. Crispr Therapeutics Ag's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$385.66 million, a 77.61% increase year over year.

What was CRSP's earnings growth in the past year?

As of Crispr Therapeutics Ag's earnings date in Invalid Date, Crispr Therapeutics Ag's earnings has grown year over year. CRSP earnings in the past year totalled -$385.66 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.